Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19

NCT04445207 is registered in ClinicalTrials.gov with Jonathan Gerber as lead sponsor.

NCT NCT04445207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19
Lead sponsor
Jonathan Gerber
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, sars-cov2